Influence of commissioned provider type and deprivation score on uptake of the childhood flu immunization by Christensen, Hannah et al.
                          Christensen, H., Reynolds, R., Kwiatkowska, R., Brooks-Pollock, E.,
Dominey, M., Finn, A., Gjini, A., Hickman, M., Roderick, M., & Yates, J.
(2019). Influence of commissioned provider type and deprivation score on
uptake of the childhood flu immunization. Journal of Public Health (United
Kingdom), [ fdz060]. https://doi.org/10.1093/pubmed/fdz060
Peer reviewed version
Link to published version (if available):
10.1093/pubmed/fdz060
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via Oxford University Press at https://academic.oup.com/jpubhealth/advance-
article/doi/10.1093/pubmed/fdz060/5514183?searchresult=1. Please refer to any applicable terms of use of the
publisher
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/user-
guides/explore-bristol-research/ebr-terms/
 Page 1 of 15 
Influence of commissioned provider type and deprivation score on uptake of the childhood flu 
immunisation. 
Christensen Hannah1, Reynolds Rosy1,2, Kwiatkowska Rachel1,2, Brooks-Pollock Ellen1,3 , Dominey 
Matthew4,5, Finn Adam1,6, Gjini Ardiana4,5, Hickman Matthew1,2, Roderick Marion6, Yates Julie4,5 
 
1. Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 
Whatley Road Bristol BS8 2PS, UK 
2. NIHR Health Protection Research Unit in Evaluation of Interventions, University of Bristol, 
Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK 
3. Bristol Veterinary School, University of Bristol, Langford House, Langford, Bristol BS40 5DU, 
UK 
4. Screening and Immunisation Team, Public Health England South West, 2 Rivergate Bristol BS1 
6EG, UK 
5. NHS England – South (South West), South Plaza, Marlborough Street, Bristol BS1 3NX, UK 
6. Department of Paediatric Immunology, Bristol Children's Hospital, Upper Maudlin St, Bristol 
BS2 8BJ, UK 
 
Contact details: 
Corresponding author: rachel.kwiatkowska@bristol.ac.uk Tel. +44 (0)117 331 0177; NIHR Health 
Protection Research Unit in Evaluation of Interventions, University of Bristol, Oakfield House, Oakfield 












 Page 2 of 15 
Abstract 
BACKGROUND: Since 2015/16 the UK seasonal influenza immunisation programme has included 
children aged 5 and 6 years. In the South West of England school-based providers, GPs or community 
pharmacies were commissioned to deliver the vaccine depending on the locality. We aimed to assess 
variation in vaccine uptake in relation to the type of commissioned provider, and levels of 
socioeconomic deprivation. 
METHODS: Data from the South West of England (2015-16 season) were analysed using multilevel 
logistic regression to assess variation in vaccine uptake by type of commissioned provider, allowing 
for clustering of children within delivery sites. 
RESULTS: Overall uptake in 5 and 6 year olds was 34.3% (37555/109404). Vaccine uptake was highest 
when commissioned through school-based programmes 50.2% (9983/19867) and lowest when 
commissioned through pharmacies, 23.1% (4269/18479). Delivery through schools resulted in less 
variation by site and equal uptake across age groups, in contrast to GP and pharmacy delivery for 
which uptake was lower among 6 year olds. Vaccine uptake decreased with increasing levels of 
deprivation across all types of commissioned provider.  
CONCLUSION: School-based programmes achieve the highest and most consistent rates of childhood 
influenza vaccination. Interventions are still needed to promote more equitable uptake of the 
childhood influenza vaccine.  
 Page 3 of 15 
Introduction 
The highest rates of influenza infection are in the very young due to their lack of previous exposure to 
the virus and absence of immunity. Young children also excrete more virus for longer periods leading 
to high rates of onwards transmission.[1]  Annually, between 10-40% of children become infected 
with influenza with symptoms varying from mild symptoms to severe illness[2,3] (around one in every 
100 children under 5 years, is hospitalised).[4]  
 
Until recently the UK influenza vaccination programme, commissioned by NHS England and Public 
Health England (PHE), targeted only vulnerable individuals at risk of serious illness or death from 
influenza: those with long term conditions or in long term care, immunocompromised, over 65 years 
of age or pregnant, and carers. Epidemiological models suggest that vaccinating healthy children 
reduces  transmission, contributing to the protection of vulnerable people and reducing the overall 
burden of community influenza;[5] accordingly the influenza vaccination schedule was modified in 
2013/14 to include live attenuated influenza vaccine (LAIV) for all children aged 2-4 years. In addition, 
a 2 year pilot vaccination programme was implemented in selected geographical areas in either 
primary (years 1 and 2: ages 5 and 6 years) or secondary (years 7 and 8: ages 11 and 12 years) 
schools.[6]  
LAIV has been shown to work well in children and has had a good safety profile over many years;[7,8] 
several other countries have recently recommended or implemented national programmes of 
vaccination of healthy children.[9] In the United States (US) influenza vaccination has been 
recommended for all children aged 6 months and above since the 2008-09 influenza season.[10] The 
UK school-based LAIV vaccination pilot demonstrated a reduction in influenza-related illness, primary 
care consultations, hospital admissions and deaths across the whole community;[11]  subsequently 
the  national programme was extended in 2015/16 to include children in years 1 and 2  with a phased 
roll out extending the eligible cohort year on year.[12]  The national commissioning strategy preferred 
a school-based vaccination programme , as the evidence from the pilots showed a higher uptake and 
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acceptability of this as  opposed to other commissioned provider types (e.g community pharmacies or 
GPs). Nonetheless any provider qualified through the national procurement framework was permitted 
to deliver the vaccine programme, subject to commissioning decisions within each Local Authority 
area. In the early years of the childhood influenza vaccination programme, commissioners were 
restricted by what was locally available which led to a range of non school-based providers being 
commissioned. 
 
People living in socio-economically deprived areas have  been shown to have a significantly higher risk 
of death due to influenza compared to those living in areas with low levels of deprivation.[13] 
Equitable delivery is a key aim of the national vaccination programme and ongoing assessment is 
essential to the success of the programme. During the period of the  original 2 year pilot programme, 
vaccine uptake was shown to vary between local areas, with deprivation and ethnicity being identified 
as predictors of low uptake.[11]   
 
The South West was one of the few regions in England in which the 2015/ 16 childhood influenza 
vaccine was delivered through a range of commissioned provider types: school- based vaccination 
teams, General Practices (GPs) or community pharmacies depending on the locality. We examined 
vaccine uptake among eligible primary school children (aged 5 and 6 years) across localities in the 
South West of England for the 2015/16 influenza season, to look for evidence of variation and 
inequalities in uptake by commissioned provider type (school-based, GP or pharmacy). 
Methods 
We obtained influenza vaccine uptake data from the two Screening and Immunisation Teams (SITs) 
covering the Public Health England South West Centre for the 2015/16 influenza season. Uptake was 
calculated as the proportion of children in the eligible population who were reported to have received 
the influenza vaccine during the campaign period (1 September 2015 to 31 January 2016). The eligible 
population was all children in school year 1 (aged 5 rising to 6 yrs) and year 2 (aged 6 rising to 7 yrs) 
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born between 1 September 2008 and 31 August 2010, as defined by their age on September 1st 
2015. [14]  The SIT provided data on the number of eligible children registered at each school (for 
areas with school- based vaccination programmes) or GP practice (for areas with GP or pharmacy 
vaccination programmes). Additional data were collected from schools in North Somerset and 
Somerset on the proportion of consent forms not returned. 
 
GP practices  
GPs were commissioned to offer vaccinations in Bath and North East Somerset, Gloucestershire, 
Swindon, Wiltshire, Devon (including Plymouth but excluding Torbay, which commissioned school 
delivery), Cornwall and Isles of Scilly for children aged 5 and 6 years old.  Data on vaccination of 
registered patients were obtained by GP practice for the entire campaign period (1 September 2015 
to 31 January 2016) with the exception of three practices in Cornwall which supplied data to the end 
of December 2015 only. 
Schools 
School nursing vaccination teams were commissioned to deliver vaccination in schools in North 
Somerset, Somerset and Torbay to children in school years 1 (children aged 5 rising to 6 years old) 
and 2 (children aged 6 rising to 7 years old). Two schools chose not to offer vaccination on site and 
pupils were directed instead to community sessions run by the vaccination provider. Vaccination data 
were obtained for the entire campaign period, aggregated by school for North Somerset and 
Somerset and by GP in Torbay.   
Pharmacies  
Vaccinations in Bristol and South Gloucestershire were commissioned through a large pharmaceutical 
chain, who, like other providers, had achieved accreditation on the national framework for 
procurement of childhood influenza vaccination to deliver the service within their own pharmacies for 
children aged 5 and 6 years.  Data on vaccinated GP registered patients were aggregated by GP 
practice, up until the end of January 2016. 
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Statistical analysis 
Statistical analyses were done using Stata v14 (StataCorp LP, 2015, College Station,TX).  When 
calculating vaccine uptake we included total number of doses of vaccine delivered, not just those 
delivered by commissioned services (i.e. an intention to treat analysis by commissioned delivery 
method). For example, vaccinations delivered by GPs in areas where school immunisation teams were 
commissioned to deliver vaccinations were included in the calculations for vaccine uptake  in that 
area.  To assess relationships between vaccine uptake and deprivation, vaccination administration 
sites were assigned to Indices of Multiple Deprivation (IMD) 2015 deprivation quintiles based upon 
the postcode address of the site because location information was unavailable for individual children 
and for all specific site catchment areas.  In analyses, all children in school year 1 were assumed to be 
aged 5 and all children in school year 2 aged 6 years.  We used multilevel logistic regression to 
investigate differences in vaccine uptake by commissioned provider type (with GPs considered the 
base case), age of the individuals and deprivation of the site allowing for nesting of children within 
delivery sites.  Univariable analyses were conducted with a single random effect for site, to assess 
significance of covariates (age, IMD quintile and vaccine delivery method) for inclusion in the 
multivariable model. Covariates were assessed in turn and retained in the multivariable model only if 
p≤0.05 in the presence of all other covariates, after which previously discarded covariates were 
reconsidered for entry. Additional random effects and interactions between covariates were explored 
in the same way. We tested for interactions between commissioned provider type and both age and 
IMD quintile, to assess whether there was any variation in uptake by commissioned provider type for 
different age groups and if there was any evidence of socio-demographic inequalities in vaccination 
uptake in relation to the type of provider. 
Results 
Data were available for 771 sites, comprising 393 GP, 302 school and 76 pharmacies which included 
54,992 children aged 5 years old and 54,412 children aged 6 years old.  Across all sites vaccine uptake 
in 5 and 6 year olds was 34.3% (37555/109404), and was slightly higher in 5 year olds (35.6%, 
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19596/54992) compared to 6 year olds (33.0%, 17959/54412). Vaccine uptake across GP 
commissioned services was 32.8% (23303/ 71058). Data were missing for the final month of the 
campaign from 3 GP practices, representing an estimated 0.15% of overall GP data. Across school-
based delivery commissioned services vaccine uptake was 50.2% (9983/ 19867); a small proportion of 
these children were vaccinated through their GP (2.3%, 199/ 8680, of children in North Somerset and 
Somerset; data were unavailable for Torbay).  Vaccination data were not available from all sites of 
pharmacy commissioned services: we found missing values for vaccination of 6-year-olds at two of 76 
pharmacy sites (176 children). In these areas 23.1% (4269/ 18479) of eligible children received 
vaccinations, although 46.2% (1974/ 4269) of these vaccinations were actually delivered via GPs. 
In univariable analyses age, commissioned provider type (GPs, schools and pharmacies) and 
deprivation quintile were associated with vaccine uptake (Table 1) and these factors remained 
independently associated in a multivariable model. The final model also included random effects at 
site level for age and commissioned provider type, and an interaction between age and commissioned 
provider type (Table 2).   
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Table 1. Univariable analysis of factors associated with vaccine uptake, allowing  
for clustering of children within delivery sites 
Variable N Nvacc (%) OR (95% CIs) p 
Age       
   5 year olds 54992 19596 (35.6) 1.00 (ref)  
   6 year olds 54412 17959 (33.0) 0.88 (0.86 to 0.90) <0.0001 
Provider type       
   GP practice 71058 23303 (32.8) 1.00 (ref)  
   School 19867 9983 (50.2) 2.23 (2.04 to 2.45)  
   Pharmacy 18479 4269 (23.1) 0.58 (0.51 to 0.67) <0.0001 
IMD quintile        
1 (least deprived) 17871 7271 40.7 1.00 (ref)  
2 22701 8687 38.3 0.88 (0.75 to 1.02)  
3 25453 9036 35.5 0.76 (0.65 to 0.89)  
4 26169 7688 29.4 0.51 (0.43 to 0.60)  
5 (most deprived) 17210 4873 28.3 0.48 (0.40 to 0.58) <0.0001 
N, number in cohort; Nvacc, number vaccinated; OR, odds ratio; 95% CIs, 
95% confidence interval 
P value refers to inclusion of the categorical variable as a set rather than 
inclusion of a single category/ quintile. 
 
  
 Page 9 of 15 
Table 2. Multivariable analysis of factors associated with vaccine uptake,  
allowing for clustering of children within delivery sites 
Variable  aOR (95% CIs) p 
Fixed effects    
Age     
   5 year olds 1.00 (ref)   
   6 year olds 0.845 0.807 to 0.885 <0.001 
Provider type    
   GP practice 1.00 (ref)   
   School 1.941 1.774 to 2.123 <0.001 
   Pharmacy 0.606 0.520 to 0.705 <0.001 
Interaction between Age and Provider type 
   6 years#School  1.187 1.091 to 1.291 <0.001 
   6 years#Pharmacy 1.011 0.904 to 1.130 0.852 
IMD quintile     
1 (least deprived) 1.00 (ref)   
2 0.889 0.792 to 0.998 0.047 
3 0.782 0.698 to 0.876 <0.001 
4 0.594 0.525 to 0.672 <0.001 
5 (most deprived) 0.551 0.481 to 0.632 <0.001 
Constant  0.684 0.616 to 0.759 <0.001 
Random effects at site level Estimate (95% CIs)  
Age 0.045 0.034 to 0.058  
6 years, 5 years    
Delivery model    
GP   0.313 0.261 to 0.375  
School   0.089 0.061 to 0.128  
Pharmacy 0.266 0.179 to 0.396  
aOR, adjusted odds ratio; 95% CIs, 95% confidence interval 




Compared to GP delivery, the odds of vaccine uptake were considerably higher (approximately 
doubled) when provided in schools, and much lower when provided in community pharmacies.  
Across all types of provider, the odds of vaccine uptake progressively reduced with increasing 
deprivation and approximately halved in the most deprived quintile compared to the least deprived.  
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Under GP and pharmacy delivery, the odds of vaccine uptake were slightly lower for 6-year-olds 
compared to 5-year-olds, but this difference was not seen with school delivery.  Site-to-site variation 
in uptake (after adjusting for age and IMD quintile) was greatest for GP and pharmacy delivery, and 
considerably less for school delivery, as shown by the random effects for commissioned provider type.  
Predicted vaccine uptake by type of provider and deprivation quintile is shown in Figure 1. 
 
 
Figure 1 Predicted mean vaccine uptake by commissioned provider (GP/ school-based/ pharmacy) and Index 
of Multiple Deprivation (IMD) quintile for 5 and 6 year olds (multivariable model) 
 
Information on children with consent forms not returned, the number of vaccination refusals and 
number of children referred to their GP for vaccination was available for schools in Somerset and 
North Somerset (286 sites, with data on 16784 children of whom 8481 were vaccinated).  In 
univariable analyses, the proportion of consent forms not being returned was not associated with age 
(p= 0.2994) but was higher for those in more deprived areas (Table 3).  The proportion of vaccinations 
actively refused was not associated with age (p= 0.6262) or IMD 2015 quintile (p= 0.9174).  Similarly, 
the proportion of children referred to primary care for vaccination was not associated with age (p= 
0.5972) or IMD 2015 quintile (p= 0.4705). 
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Table 3. Odds ratio of consent form not being returned by  
Indices of Deprivation 2015 quintile in North Somerset and  
Somerset schools, univariable analysis allowing for clustering  
of children within delivery sites 
IMD quintile OR (95% CIs) P 
1 (least deprived) 1.00 (ref)  
2 1.15 (0.97 to 1.36)  
3 1.26 (1.07 to 1.49)  
4 1.92 (1.54 to 2.37)  
5 (most deprived) 2.19 (1.72 to 2.80) < 0.0001 
OR, odds ratio; 95% CIs, 95% confidence interval 
P value refers to inclusion of IMD quintile as a set 
rather than inclusion of a single quintile. 
 
Discussion 
Main findings of this study 
The highest overall vaccination rates were achieved through school-based programmes; rates were 
lower in areas which offered vaccination via GPs and lower still in areas offering pharmacy-based 
vaccination. There was variation in vaccination uptake between sites for all commissioned providers 
but, after controlling for age and IMD quintile, this was very much less for school-based provision 
than for other methods. School-based provision also achieved equal vaccination uptake for both age 
groups, in contrast with pharmacy and GP provision which resulted in slightly lower vaccination 
uptake among 6 year olds compared with 5 year olds. 
What is already known on this topic 
Relatively high uptake of vaccines through schools has been reported in relation to adolescent 
vaccination programmes such as those for Human Papillomavirus (HPV) and Meningitis A,C,W and Y 
(MenACWY).[15–17] There are few published studies comparing different settings for vaccine 
provision in younger children, however surveillance data from the 2014-15 influenza season indicate 
that overall vaccine uptake for primary school children (aged 4 to 11 years) in England was higher in 
school-based pilots as compared with provision through GPs and community pharmacies .[18]  
 
Low uptake of vaccines through pharmacies was also reflected in an influenza surveillance report 
from the 2015-16 year, since the South West was one of the few areas in England where  vaccination 
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was offered through pharmacies instead of schools and vaccine uptake in this region was lower than 
the national average for 5 and 6 year olds.[19] A review of evaluations of community pharmacy 
delivery initiatives has shown no evidence that they increase overall uptake of the influenza vaccine 
(in adults and children) compared to standard delivery through GPs, though they were deemed 
acceptable and convenient venues for vaccination.[20] 
 
Associations between socio-economic deprivation and low vaccine uptake are widely reported, 
although evaluations of adolescent vaccination programmes such as HPV or adolescent boosters have 
found that school-based delivery programmes mitigate this to some extent.[17,21,22] This could 
reflect differences in consent mechanisms in primary and secondary schools, or in levels of perceived 
risk of disease and effectiveness of vaccine for teenage vaccines as compared to the influenza 
vaccine.[23,24] It is recognised that factors contributing to low vaccine uptake among children from a 
lower socio-economic background are numerous and complex; hence locally developed, 
multicomponent interventions may be required to ensure equity in vaccine delivery.[15,25] 
 
What this study adds 
To our knowledge this is the first study examining uptake of LAIV among children which examines the 
interacting effects of deprivation score and age with commissioned type of vaccine provider (school-
based, GP or pharmacy). As of 2018 almost all areas in England are commissioning school-based 
providers to deliver the vaccine, due to evidence that this increases uptake. Our findings strengthen 
the rationale for this approach and provide evidence that it promotes equitable uptake by reducing 
variation by site and between age groups. 
 
In addition, whilst there remains a socio-economic gradient in uptake of the childhood influenza 
vaccine regardless of the commissioned provider type, we have shown that on average vaccine 
uptake was higher in schools- based programme in the most deprived areas than in GP programmes 
in the most affluent areas (see Figure 1). For areas commissioning a school-based programme, higher 
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levels of deprivation were associated with lower returns for consent forms but did not affect the 
proportion of vaccines that were actively refused. The association between deprivation and low rates 
of consent form returns in schools is likely to have been attenuated by differences in provider 
practices. In one school within a deprived area, the standard approach of sending consent forms 
electronically to the school to print and distribute to parents resulted in such poor returns that the 
service providers attended in person to distribute forms to parents at the school gates . Rates of 
consent and uptake of the vaccine in this site were subsequently very high. This example highlights 
the need for vaccine delivery initiatives that reflect the local context, for instance addressing the 
multiple and complex drivers behind non-return of consent forms in more deprived areas, in order to 
reduce inequalities in uptake of the childhood influenza vaccine. 
 
Limitations of this study 
There are limitations to this study, which is observational and may be subject to ecological bias and 
confounding by factors that were not adjusted for in the multivariable analysis such as child ethnicity, 
religion, and family size.[11,26] Since deprivation scores were assigned using postcodes of vaccination 
sites we may have inaccurately judged levels of deprivation for some children, however our approach 
is arguably more useful in terms of informing interventions to tackle social inequalities at the site level 
(within schools, GP practices or pharmacies)   Our results may not be entirely generalisable, 
particularly given the fact that only one pharmacy chain was involved in the delivery of vaccines 
during the study period which might not reflect the performance of other pharmacy providers. 
 
The degree of clustering at site level may have varied depending on the type of provider; on average 
schools cater for fewer children (median 51 children) than GP practices (median 169) or pharmacies 
(median 246) and there is likely to be more interaction within groups of children and parents 
associated with schools than with other sites. To counter this, we used appropriate multilevel 
modelling methods to take account of the clustered nature of the data (by school or GP) and avoid 
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bias in estimates and unduly narrow standard errors. By including random effects for site, we 
demonstrated less variation in vaccination uptake between school sites as compared to GPs and 
pharmacies: this is the reverse of what we would see if clustering were more pronounced in school 
commissioned areas and gives us confidence in our conclusion that school-based delivery is more 
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